Evidence map›Paper›PMID 36382105›Full record

ArticleNeuro-oncology advances

Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue.

Elizabeth Cooper, Zoe Woolf, Molly E V Swanson, Jason Correia, Patrick Schweder, Edward Mee, Peter Heppner, Clinton Turner, Richard L M Faull, Emma L Scotter and 5 more

Open access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Drug resistance in glioblastoma: from chemo- to immunotherapy.Cancer drug resistance (Alhambra, Calif.) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Elizabeth CooperDepartment of Pharmacology, University of Auckland, Auckland, New Zealand.
Zoe WoolfDepartment of Pharmacology, University of Auckland, Auckland, New Zealand.
Molly E V SwansonDepartment of Biological Sciences, University of Auckland, Auckland, New Zealand.
Jason CorreiaNeurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.
Patrick SchwederNeurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.
Edward MeeNeurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0003-3514-8067
Peter HeppnerDepartment of Neurosurgery, Auckland City Hospital, Auckland, New Zealand.ORCID https://orcid.org/0000-0001-9907-6424
Clinton TurnerNeurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-2138-7633
Richard L M FaullNeurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.
Emma L ScotterDepartment of Biological Sciences, University of Auckland, Auckland, New Zealand.
William A DennyAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.
Peter J ChoiAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.
Mike DragunowDepartment of Pharmacology, University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0003-1711-1631
Jiney JoseAuckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.
Thomas I-H ParkDepartment of Pharmacology, University of Auckland, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-7995-8865
University of Auckland · NZAuckland City Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults. Whilst the role of the efflux transporters are well established in GBM, the expression and function of uptake transporters, such as the organic anion transporting polypeptide (OATP) family, are not well understood. OATPs possess broad substrate specificity that includes anti-cancer agents; therefore, we sought to investigate the expression of four OATP isoforms in human GBM cell types using patient tumor tissue. Methods: We used fluorescent immunohistochemical labeling of paraffin-embedded surgically resected tissues and single-cell image analysis methods to explore the expression of the OATP isoforms in different tumor cell types through co-labeling with cell-type specific markers, such as IBA1 (pan-myeloid), GFAP (tumor cell), PDGFRβ (stromal cell), and UEA-1-lectin (endothelial). Results: We found significant over-expression of all the OATP isoforms (OATP1A2, 2B1, 1C1 and 4A1) in GBM tumor sections when compared to non-neoplastic brain. A single-cell image analysis revealed that OATPs were significantly upregulated throughout the tumor parenchyma, with significantly higher expression found on lectin-positive blood vessels and IBA1-positive myeloid cells in GBM compared to non-tumor brain tissue. Qualitative analysis of the four OATP isoforms demonstrated greater expression of OATP4A1 in peri-necrotic regions of GBM tissue, which correlated with hypoxia-related markers within the Ivy GAP RNAseq dataset. Conclusion: Here, we demonstrate, for the first time, the protein expression of four OATPs in human GBM tissue, including upregulation within the tumor microenvironment by myeloid cells and tumor vasculature, and isoform-specific upregulation within hypoxic niches.

Indexed as

glioblastomaOATPorganic anion transporting polypeptidestumor microenvironment

Identifiers

PMID36382105
PMCPMC9653174
OpenAlexW4306165723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.